| 000 | a | ||
|---|---|---|---|
| 999 |
_c9632 _d9632 |
||
| 003 | OSt | ||
| 005 | 20191009094803.0 | ||
| 008 | 191009b xxu||||| |||| 00| 0 eng d | ||
| 040 |
_aAIKTC-KRRC _cAIKTC-KRRC |
||
| 100 |
_99775 _aKirpekar, Vivek C. |
||
| 245 | _a276© 2019 Indian Journal of Pharmacology Published by Wolters Kluwer - MedknowLurasidone‑induced anemia: Is there a need for hematological monitoring? | ||
| 250 | _aVol.51(4), July-Aug | ||
| 260 |
_aMumbai _bWolter Kluwer _c2019 |
||
| 300 | _a266-278p. | ||
| 520 | _aLurasidone is a newer drug used for treating schizophrenia and depression in bipolar disorder. Although comparatively safe, some side effects can occur with its use such as akathisia, extrapyramidal reaction, metabolic syndrome, and hyperprolactinemia. Blood dyscrasia with lurasidone is rarely reported in the literature except for few case reports. We present two cases of schizophrenia, treated with lurasidone developing anemia after variable period of treatment and reverting after stopping lurasidone. These cases emphasize the timely monitoring of blood parameters for prevention or early detection of anemia in patients treated with lurasidone. | ||
| 650 | 0 |
_94774 _aPHARMACOLOGY |
|
| 700 |
_99777 _aFaye, Abhijeet D. |
||
| 773 | 0 |
_x0253-7613 _tIndian Journal of Pharmacology _dAndheri - Mumbai Wolters Kluwer India Private Limited |
|
| 856 |
_uhttp://www.ijp-online.com/temp/IndianJPharmacol514276-864315_001424.pdf _yClick here |
||
| 942 |
_2ddc _cAR |
||